Bromfenac 0.09 % Ophthalmic Solution

DRUG3 trials

Sponsors

Azienda USL Reggio Emilia - IRCCS, Nemocnice Kolín, Pomeranian Medical University Szczecin

Conditions

Cataract SurgeryInflammation EyeMacular OedemaNSAID (Non-Steroidal Anti-Inflammatory Drug)Pseudophakic Cystoid Macular Edema

Phase 4

Bromfenac Versus Dexamethasone After Cataract Surgery

CompletedNCT03317847

Azienda USL Reggio Emilia - IRCCSInflammation Eye

Start: 2017-10-16End: 2019-12-21Updated: 2025-06-25

Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification

CompletedNCT07696104

Pomeranian Medical University SzczecinPseudophakic Cystoid Macular Edema

Start: 2020-10-14End: 2024-05-22Updated: 2026-07-10

Unknown Phase

Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery

RecruitingNCT07178639

Nemocnice KolínCataract Surgery, Macular Oedema, NSAID (Non-Steroidal Anti-Inflammatory Drug)

Start: 2025-08-01End: 2026-02-28Target: 150Updated: 2025-09-17

Related Papers

Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.

2020-05-2117 citations

Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.

2019-09-039 citations